You can now read 10 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe


With new tools, Novartis targets brain disease

Novartis is returning to an area of medical research that has defeated drug companies time and again over the past decade: diseases of the brain — from depression to Parkinson’s — that affect millions of people worldwide.

The Swiss drug giant has relaunched a research group specializing in neuroscience, basing it at its giant research campus in Cambridge and luring a prominent neurobiologist from Stanford University, to take advantage of major new tools that are giving scientists greater insight into how the brain and the diseases that afflict it work.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week